Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-21-236407
Filing Date
2021-08-04
Accepted
2021-08-04 17:11:00
Documents
2
Group Members
BCIP LIFE SCIENCES ASSOCIATES, LPBCLS II INVESTCO, LP

Document Format Files

Seq Description Document Type Size
1 SC 13D d243821dsc13d.htm SC 13D 81292
2 EX-99.A d243821dex99a.htm EX-99.A 10202
  Complete submission text file 0001193125-21-236407.txt   93018
Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 6175162000
Bain Capital Life Sciences Fund II, L.P. (Filed by) CIK: 0001773187 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Subject) CIK: 0001861560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92743 | Film No.: 211145099
SIC: 2834 Pharmaceutical Preparations